# 开发和评估专家与机器间道德协作的框架

发布时间：2024年11月17日

`其他` `精准医学`

> Framework for developing and evaluating ethical collaboration between expert and machine

# 摘要

> 精准医学是一种前景可观的手段，适用于像冠状动脉疾病（CAD）、耐药性癫痫（DRE）等高死亡率疾病，以及 1 型糖尿病（T1D）等慢性疾病的可及性疾病诊断和个性化干预规划。借助人工智能（AI），精准医学通过清晰地模拟病理生理差异，为个体患者量身定制诊断和治疗方案。然而，AI 在医疗应用中的采用面临诸多重大挑战，比如跨中心、人口统计学和合并症方面的通用性不佳，临床术语的解释能力有限，以及在伦理决策方面缺乏信任。本文提出了一个框架，用于开发和从伦理角度评估专家指导的多模态 AI，以应对精准医学中 AI 集成的这些难题。我们通过 1 型糖尿病胰岛素管理的案例研究来阐释这个框架。为确保伦理考量和临床医生的参与，我们采用了一种协同设计的方法，即 AI 起辅助作用，最终的诊断或治疗计划由临床医生和 AI 合作得出。

> Precision medicine is a promising approach for accessible disease diagnosis and personalized intervention planning in high-mortality diseases such as coronary artery disease (CAD), drug-resistant epilepsy (DRE), and chronic illnesses like Type 1 diabetes (T1D). By leveraging artificial intelligence (AI), precision medicine tailors diagnosis and treatment solutions to individual patients by explicitly modeling variance in pathophysiology. However, the adoption of AI in medical applications faces significant challenges, including poor generalizability across centers, demographics, and comorbidities, limited explainability in clinical terms, and a lack of trust in ethical decision-making. This paper proposes a framework to develop and ethically evaluate expert-guided multi-modal AI, addressing these challenges in AI integration within precision medicine. We illustrate this framework with case study on insulin management for T1D. To ensure ethical considerations and clinician engagement, we adopt a co-design approach where AI serves an assistive role, with final diagnoses or treatment plans emerging from collaboration between clinicians and AI.

[Arxiv](https://arxiv.org/abs/2411.10983)